Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0000875320-24-000154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2024-05-15 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale | $430.93 | -32 | 55.3K | -0.1% | -$13.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-15 | S | D | 32 | $430.93 | 55,325 | D | — | — |